Testing effectiveness (Phase 2)Ended earlyNCT04936113
What this trial is testing
Continued Safety Evaluation of FB-401 in Children, Adolescents and Adults (2 Years and Older) With Mild to Moderate Atopic Dermatitis Previously Enrolled in the FB401-01 Study
Who this might be right for
Atopic Dermatitis
Forte Biosciences, Inc. 36